Spring Bank Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SBPH and buy or sell other stocks, ETFs, and their options commission-free!About SBPH
F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies.
CEONeil Brewis, PhD
CEONeil Brewis, PhD
Employees—
Employees—
HeadquartersCambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded2002
Founded2002
Employees—
Employees—
SBPH Key Statistics
Market cap156.51M
Market cap156.51M
Price-Earnings ratio-3.44
Price-Earnings ratio-3.44
Dividend yield—
Dividend yield—
Average volume1.24M
Average volume1.24M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.12
52 Week high$7.12
52 Week low$2.07
52 Week low$2.07
Stock Snapshot
The current Spring Bank Pharmaceuticals(SBPH) stock price is $7.12, with a market capitalization of 156.51M. The stock trades at a price-to-earnings (P/E) ratio of -3.44.
Spring Bank Pharmaceuticals(SBPH) stock opened on 2026-01-02 at —. The price climbed to — and dipped to —.
The Spring Bank Pharmaceuticals(SBPH)'s current trading volume is 0, compared to an average daily volume of 1.24M.
In the last year, Spring Bank Pharmaceuticals(SBPH) shares hit a 52-week high of $7.12 and a 52-week low of $2.07.
In the last year, Spring Bank Pharmaceuticals(SBPH) shares hit a 52-week high of $7.12 and a 52-week low of $2.07.
People also own
Based on the portfolios of people who own SBPH. This list is generated using Robinhood data, and it’s not a recommendation.